B. Lakshminarayana's Insider Trades & SAST Disclosures
B. Lakshminarayana's most recent trade in Natco Pharma Ltd. was a Disposal of 2,000 Equity Shares done at an average price of Rs. 1391.6 . Disclosure was reported to the exchange on Dec. 31, 2024 under the SEBI (Prohibition of Insider Trading) Regulations, 2015.
No reported SAST transactions available for B. Lakshminarayana in the Trendlyne database.
| Stock | Client Name | Client Category | Action* | Reported To/By Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Period | Regulation (Insider/SAST) | Security Type | Mode |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Natco Pharma | Lakshminarayana Bolisetty | Director | Disposal | 31 Dec 2024 | 2,000 | 0 (0%) | 0.00% | 1391.6 | 2,783,220 | 30 Dec 2024 30 Dec 2024 |
Insider Trading | Equity Shares | Market Sale |
| Divi's Laboratories | B. Lakshminarayana | Designated Person | Disposal | 07 Jun 2021 | 1,500 | 24,100 (0.01%) | 0.00% | 4183.8 | 6,275,751 | 01 Jun 2021 01 Jun 2021 |
Insider Trading | Equity Shares | Market Sale |
Acquisition (Buy): Purchase of shares
Disposal (Sell): Sale of shares
Pledge: Shares being used by promoters as collateral for loans. Usually a negative signal.
Revoke: When shares are released from a pledge. Usually a positive signal.
Invoke: When pledged shares are invoked by companies/banks who have provided the collateral, which may result in acquisition of stake in the company. Usually a negative signal.
Security Type: Share/ Warrants / Convertible Debentures
Kind of transaction Mode: Public rights/ preferential offer / off market / inter-se transfer/ Market Sale
Data as reported to BSE and NSE
Insider trading data is from Disclosure under SEBI (Prohibition of Insider Trading) Regulations, 2015.